Pharmacology of itraconazole

K De Beule, J Van Gestel - Drugs, 2001 - Springer
Itraconazole is a triazole antifungal agent that has a broad spectrum of activity and is well
tolerated. Itraconazole is highly efficacious, particularly because its main metabolite, hydroxy …

Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics

L Willems, R Van der Geest… - Journal of clinical …, 2001 - Wiley Online Library
Itraconazole is a triazole antifungal agent with a broad spectrum of activity. It is well tolerated
and highly efficacious, particularly because its main metabolite, hydroxy‐itraconazole, also …

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution

GP Rosen, K Nielsen, S Glenn, J Abelson… - Journal of Pediatric …, 2005 - journals.lww.com
The purpose of this study was to determine the incidence of fungal infections in pediatric
hematology and oncology (PHO) patients and to describe variations regarding site of …

Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis

Z Kaya, T Gursel, U Kocak, YZ Aral… - Pediatric blood & …, 2009 - Wiley Online Library
Background Children with acute leukemia have increased risk for invasive fungal infections
(IFI) but the role of long term antifungal prophylaxis (AFP) in morbidity and mortality of IFI is …

[PDF][PDF] Aspergillus, Penicillium and related species reported from Turkey

A Ahmet - Mycotaxon, 2004 - researchgate.net
Aspergillus, Penicillium and related species reported from Turkey Page 1 1 Mycotaxon Vol.
89, No: 1, pp. 155-157, January-March, 2004. Journal home : http://www.mycotaxon.com …

Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution

E Castagnola, I Caviglia, A Pistorio, F Fioredda… - European Journal of …, 2005 - Elsevier
The incidence rate (IR) of bloodstream infections (BI) and invasive mycoses (IM) during
chemotherapy for paediatric acute lymphoblastic (ALL) or non-lymphoblastic leukaemias …

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

JE Clarkson, HV Worthington… - Cochrane Database of …, 2007 - cochranelibrary.com
Background Treatment of cancer is increasingly more effective but is associated with short
and long term side effects. Oral side effects remain a major source of illness despite the use …

Significance of oral Candida infections in children with cancer

M Alberth, L Majoros, G Kovalecz, E Borbás… - Pathology & oncology …, 2006 - Springer
Candidiasis is common in children with cancer, particularly during periods of severe
immunosuppression and neutropenia. Our aim was to study the microbiological changes in …

Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized …

S Mandhaniya, C Swaroop, S Thulkar… - Journal of Pediatric …, 2011 - journals.lww.com
Purpose: Invasive fungal infections (IFI) are a major cause of infection-related mortality
during induction chemotherapy of acute leukemia (AL) patients. Data on antifungal …

Infections in pediatric patients with hematologic malignancies

LC Bailey, AF Reilly, SR Rheingold - Seminars in hematology, 2009 - Elsevier
Despite significant advances in supportive care, infection remains second only to
malignancy as a cause of death in pediatric oncology patients, and infection accounts for a …